Colgate-Palmolive Company (CL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
25 Mar, 2026Executive summary
Annual Meeting scheduled for May 8, 2026, will be held virtually, allowing electronic voting and Q&A participation.
Key priorities include accelerating growth, maximizing efficiency, driving cash flow, and advancing sustainability and inclusion.
The 2030 strategy focuses on global brand reach, science-based innovation, omni-channel demand, data/AI, and inclusive culture.
Board and management emphasize strong corporate governance, stakeholder value, and continuous improvement.
Voting matters and shareholder proposals
Proposals include electing ten directors, ratifying PricewaterhouseCoopers LLP as auditor, advisory vote on executive compensation, and two shareholder proposals.
Board recommends voting FOR all company proposals and AGAINST both shareholder proposals (removal of DEI from board considerations and requirement for an independent board chairman).
Shareholder proposals address board diversity criteria and board leadership structure; Board opposes both, citing strategic and governance reasons.
Board of directors and corporate governance
Board consists of ten nominees, nine of whom are independent; diverse in gender, ethnicity, and experience.
Board committees (Audit, Finance, NGCR, P&O) are fully independent and oversee key areas including risk, sustainability, and compensation.
Lead Director role is robust, with significant authority and clear duties; annual board and committee self-evaluations are conducted.
Board refreshment is ensured through mandatory retirement age and directorship limits.
Latest events from Colgate-Palmolive Company
- Hill’s Pet Nutrition drives growth with innovation, margin recovery, and global expansion focus.CL
Goldman Sachs Global Staples Forum9 Jul 2026 - Strategic innovation, premiumization, and flexible operations drive growth and margin expansion.CL
UBS Global Consumer and Retail Conference8 Jul 2026 - Record sales, margin gains, and robust cash flow position for continued growth in 2025.CL
Q4 20248 Jul 2026 - Breakthrough innovation, data-driven execution, and balanced growth drive strong global performance.CL
JPMorgan 15th Annual U.S. All Stars Conference8 Jul 2026 - Transformation, innovation, and global agility drive growth amid regional and market challenges.CL
23rd annual dbAccess Global Consumer Conference3 Jun 2026 - Board elections, 2025 results, and 2030 strategy highlighted; key shareholder proposals rejected.CL
AGM 202614 May 2026 - Net sales up 8.4% to $5.3B, with strong growth in Latin America and EMEA offsetting higher costs.CL
Q1 20261 May 2026 - Director elections, auditor ratification, and key shareholder proposals headline the annual meeting.CL
Proxy filing16 Apr 2026 - Board recommends voting for all directors and auditor, against DEI removal and independent chair.CL
Proxy filing25 Mar 2026